Phocas Financial Corp. Amneal Pharmaceuticals, Inc. Transaction History
Phocas Financial Corp.
- $695 Billion
- Q2 2025
A detailed history of Phocas Financial Corp. transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Phocas Financial Corp. holds 1,259,564 shares of AMRX stock, worth $13.3 Million. This represents 1.47% of its overall portfolio holdings.
Number of Shares
1,259,564
Previous 1,259,378
0.01%
Holding current value
$13.3 Million
Previous $10.6 Billion
3.45%
% of portfolio
1.47%
Previous 1.62%
Shares
10 transactions
Others Institutions Holding AMRX
# of Institutions
249Shares Held
145MCall Options Held
194KPut Options Held
49.3K-
Vanguard Group Inc Valley Forge, PA17.6MShares$185 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$130 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$124 Million2.18% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$119 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$59.3 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.6B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...